Nov 20,2018

Insulet’s Omnipod DASH™ Insulin Management System Receives ISO 27001 Certification for Information Security

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced it has received ISO (International Standards Organization) 27001 certification of its Omnipod DASH™ System.

PRODUCT

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Nov 21,2018

Wockhardt Hospital, SOBO Launches a Diabetes Clinic Powered by Wellthy Therapeutics

Wockhardt Hospital, Mumbai Central, a JCI & NABH Accredited hospitals in association with Wellthy Therapeutics has launched a Diabetes Clinic whose patients will get access to their digital therapeutic suite for Diabetes (WellD).

COLLABORATION PARTNERSHIP

#product & service

#dtx

View Analyst & Ambassador Comments
Go to original news
Nov 21,2018

Medtronic to Acquire Nutrino Health

Medtronic plc (NYSE:MDT), a global leader in medical technology, and Nutrino Health Ltd., a leading provider of nutrition-related data services, analytics, and technologies, today announced the companies have entered into a definitive agreement under which Medtronic will acquire Nutrino. The acquisition is expected to close in Medtronic's third fiscal quarter, ending January 25, 2019, subject to the satisfaction of certain customary closing conditions.

COLLABORATION MERGERS & ACQUISITION

#closed loop

#mobile app

View Analyst & Ambassador Comments
Go to original news
Nov 27,2018

Eversense CGM Wins a 2018 “Best of What’s New” Award

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today has announced that the Eversense® Continuous Glucose Monitoring (CGM) System has been awarded one of Popular Science’s 2018 “Best of What’s New” Awards in the Health category.

View Analyst & Ambassador Comments
Go to original news
Nov 27,2018

Fit4D (now named as Cecelia Health) and WellCare Partner to Deliver Diabetes Management Solution to Members in New York

Fit4D (now named as Cecelia Health), a leading tech-enabled diabetes management company based in New York City, and WellCare of New York, Inc., a WellCare Health Plans, Inc. (NYSE: WCG) company, announced today a partnership to deliver Fit4D’s personalized coaching program to WellCare members living with Type 2 diabetes in the state of New York.

COLLABORATION PARTNERSHIP

#insurance

#coaching

View Analyst & Ambassador Comments
Go to original news
Dec 10,2018

POPS! Diabetes Care scores 510(k) for connected glucose monitoring system

Last week, the FDA granted a 510(k) clearance to POPS! Diabetes Care for its latest product, the POPS! one blood glucose monitoring system.

REGULATORY FDA

#bgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 13,2018

Tidepool lands $6M grant to develop hybrid closed-loop automated insulin delivery app

Diabetes management startup Tidepool has just locked in a $6 million grant from the Leona M. and Harry B. Helmsley Charitable Trust and JDRF in order to kick off develop an app for hybrid closed-loop automated insulin delivery.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Dec 01,2018

Tidepool to Develop an FDA-Regulated Insulin Delivery App with Support from JDRF and The Helmsley Charitable Trust

Tidepool—a nonprofit software organization—is expanding their team to develop and support Tidepool Loop, a hybrid closed loop automated insulin delivery app. The app, which Tidepool will submit to the FDA for review, will be based on the current DIY Loop, and will enable a larger contingent of the type 1 diabetes (T1D) community to better manage their blood-glucose levels from their smartphones.

PRODUCT

#closed loop

View Analyst & Ambassador Comments
Go to original news
Dec 04,2018

Fit4D (now named Cecelia Health) Elects Bradley (Brad) Wilson as Chairman

Fit4D Inc. (now named Cecelia Health), a leading technology-enabled diabetes management company based in New York City, today announced the election of J. Bradley Wilson, currently one of the company’s Board Directors, to the role as Chairman of the Board effective immediately.

View Analyst & Ambassador Comments
Go to original news
Dec 12,2018

DarioHealth to Offer Diabetes Content and Coaching to Patients in Canada in Collaboration With LMC Healthcare

DarioHealth Corp., a leading global digital health company with mobile health and big data solutions, announced today that Toronto-based LMC Healthcare, Canada's largest specialist care provider in diabetes and endocrinology, will work with Dario who will provide digital content and coaching services across Canada for patients with diabetes. LMC has 11 clinics and 19 clinical research sites that provide care to over 39,000 patients with diabetes in Canada.

COLLABORATION PARTNERSHIP

#institution

#coaching

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES